DekaBank Deutsche Girozentrale Has $148.59 Million Stake in Colgate-Palmolive (NYSE:CL)

DekaBank Deutsche Girozentrale lowered its position in Colgate-Palmolive (NYSE:CL) by 0.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,512,001 shares of the company’s stock after selling 5,318 shares during the period. DekaBank Deutsche Girozentrale owned 0.18% of Colgate-Palmolive worth $148,589,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Mitchell Sinkler & Starr PA boosted its stake in shares of Colgate-Palmolive by 92.6% during the 4th quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock worth $3,659,000 after acquiring an additional 22,073 shares in the last quarter. Stonehage Fleming Financial Services Holdings Ltd boosted its position in Colgate-Palmolive by 57.1% during the fourth quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock worth $30,594,000 after purchasing an additional 139,429 shares during the period. D L Carlson Investment Group Inc. acquired a new position in Colgate-Palmolive during the fourth quarter valued at approximately $3,269,000. Diversify Advisory Services LLC bought a new position in shares of Colgate-Palmolive in the first quarter valued at approximately $911,000. Finally, TD Asset Management Inc lifted its stake in shares of Colgate-Palmolive by 2.4% in the first quarter. TD Asset Management Inc now owns 1,154,566 shares of the company’s stock worth $103,969,000 after buying an additional 26,987 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $106.35 on Friday. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. The stock’s fifty day simple moving average is $101.93 and its 200 day simple moving average is $95.04. Colgate-Palmolive has a one year low of $67.62 and a one year high of $109.30. The firm has a market cap of $87.25 billion, a price-to-earnings ratio of 33.66, a P/E/G ratio of 3.78 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.87 by $0.04. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business had revenue of $5.06 billion for the quarter, compared to analyst estimates of $5 billion. During the same quarter in the prior year, the firm earned $0.77 EPS. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. On average, analysts expect that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.88%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on CL shares. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their target price for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. Sanford C. Bernstein lifted their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research note on Tuesday, July 30th. Bank of America increased their target price on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. Citigroup lifted their price target on Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Finally, Barclays increased their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average price target of $102.63.

Insider Transactions at Colgate-Palmolive

In other news, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the sale, the insider now owns 5,146 shares in the company, valued at $529,729.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Panagiotis Tsourapas sold 14,794 shares of the stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the transaction, the insider now owns 5,146 shares in the company, valued at $529,729.24. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock valued at $4,486,063 in the last three months. 0.34% of the stock is owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.